Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Operating Expenses | 59,516 | 428 | 2,659 | 5,300 | 15,197 |
| Operating Income | -59,516 | -428 | -2,659 | -5,300 | -15,197 |
| Other Income | 384 | 427 | 451 | 413 | 204 |
| Pre-tax Income | -59,132 | -1 | -2,208 | -4,887 | -14,993 |
| Net Income Continuous | -59,132 | -1 | -2,208 | -4,887 | -14,993 |
| Net Income | $-59,132 | $-1 | $-2,208 | $-4,887 | $-14,993 |
| EPS Basic Total Ops | -45.20 | 0.00 | -1.80 | -4.00 | -12.80 |
| EPS Basic Continuous Ops | -45.16 | 0.00 | -1.88 | -4.14 | -12.74 |
| EPS Diluted Total Ops | -45.20 | 0.00 | -1.80 | -4.00 | -12.80 |
| EPS Diluted Continuous Ops | -45.16 | 0.00 | -1.88 | -4.11 | -12.74 |
| EBITDA(a) | $-59,394 | $-356 | $-2,597 | $-5,300 | $-15,197 |